Barclays Maintains Overweight on RH, Lowers Price Target to $202

Benzinga Newsdesk www.benzinga.com Negative 85.6%

Neg 85.6% Neu 0% Pos 0%

Barclays analyst Seth Sigman maintains RH (NYSE:RH) with a Overweight and lowers the price target from $283 to $202.

Comments

No comments yet. Be the first!